Keyphrases
Phosphodiesterase Type 5 Inhibitors
100%
Sildenafil
100%
Cerebral Arteries
100%
Guinea pig
100%
Cyclic GMP
60%
Hydrolysis
30%
Migraine
10%
Nitric Oxide Donors
10%
Vascular Headache
10%
Endothelium-dependent Vasodilation
10%
Headache
10%
Sodium Nitroprusside
10%
Basilar Artery
10%
High Concentration
10%
Human Arteries
10%
Dilatation
10%
Middle Cerebral Artery
10%
Selective Inhibitor
10%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphodiesterase V
100%
Sildenafil
100%
Guinea Pig
100%
Cyclic GMP
54%
Phosphodiesterase V Inhibitor
9%
Nitric Oxide Donor
9%
Messenger RNA
9%
Migraine
9%
Vascular Headache
9%
Nitroprusside Sodium
9%
Headache
9%
Medicine and Dentistry
Sildenafil
100%
Phosphodiesterase V
100%
Cyclic GMP
54%
Enzymatic Hydrolysis
27%
In Vitro
18%
Headache
9%
Basilar Artery
9%
Migraine
9%
Phosphodiesterase V Inhibitor
9%
Messenger RNA
9%
Vasodilatation
9%
Nitric Oxide Donor
9%
Artery Dilatation
9%
Sodium Nitroprusside
9%
Middle Cerebral Artery
9%
Neuroscience
Sildenafil
100%
Phosphodiesterase V
100%
Cyclic Guanosine Monophosphate
54%
Headache
18%
In Vivo
18%
In Vitro
18%
Middle Cerebral Artery
9%
Vasoactive
9%
Nitric Oxide
9%
Migraine
9%
Sodium Nitroprusside
9%
Messenger RNA
9%
Basilar Artery
9%
Cyclic Adenosine Monophosphate
9%